Results 181 to 190 of about 23,952,755 (264)

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers. [PDF]

Cell Rep Med
Theardy MS, Takeda M, Sorokin A, Chen S, Yang Z, Wang X, Kanikarla P, Coker O, Nguyen P, Wei Y, Yao J, Yan L, Jin Y, Cai Y, Paku M, Chen Z, Li KZ, Citron F, Tomihara H, Gao S, Deem AK, Zhao J, Wang H, Hanash S, DePinho RA, Maitra A, Draetta GF, Ying H, Kopetz S, Yao W.   +29 more
europepmc   +1 more source

Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. [PDF]

Rheumatology (Oxford)
Carnazzo V, Gulli F, Basile V, Di Santo R, Niccolini B, Redi S, Vinante I, Napodano C, Pocino K, Rapaccini GL, Lizzio MM, Marino M, Ciasca G, Basile U.   +13 more
europepmc   +1 more source

Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular Stiffness. [PDF]

J Clin Med, 2023
Sági B, Kun S, Jakabfi-Csepregi RK, Sulyok E, Csiky B.   +4 more
europepmc   +1 more source

2- O -Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection

, 2015
Atsuko Hayashida, Shiro Amano, Richard L. Gallo, Robert J. Linhardt, Jian Liu, Pyong Woo Park   +5 more
openalex   +1 more source

GOPC facilitates the sorting of syndecan-1 in polarized epithelial cells

, 2022
Charlotte Ford, Christopher G. Burd
openalex   +2 more sources

Syndecan-1 and -4 Synthesized Simultaneously by Mouse Mammary Gland Epithelial Cells Bear Heparan Sulfate Chains That Are Apparently Structurally Indistinguishable [PDF]

, 2003
Masahiro Zako, Jianying Dong, Olga Goldberger, Merton Bernfield, John T. Gallagher, Jon A. Deakin   +5 more
openalex   +1 more source

Tranexamic acid did not attenuate the acute rise in plasma syndecan-1 in a severely injured cohort: a laboratory analysis of the PATCH clinical trial. [PDF]

Intensive Care Med Exp
Milford EM, Marjanovic D, Ho H, Wallis S, Draxler DF, Mitra B, Gruen RL, Medcalf R, Bernard S, McArthur C, Meagele M, Burns B, Gantner D, Reade MC.   +13 more
europepmc   +1 more source

Review for "Plasma syndecan‐1 concentration as a biomarker for endothelial glycocalyx degradation in septic adult horses"

, 2022
Jenifer R. Gold
openalex   +1 more source

Syndecan‑1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target. [PDF]

Oncol Lett, 2023
Akca D, Simon A, Buettner R, Bruns C, Schroeder W, Zander T, Gebauer F, Quaas A.   +7 more
europepmc   +1 more source

Syndecan-1 Expression and Soluble Syndecan-1 in Head and Neck and Lung Carcinomas [PDF]

, 2006
Anttonen, Anu
core